Back to Search
ANUSHRI OZA, M.D.
M.D.
Pediatrics Physician
NPI: 1356736508Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
A160851(CA)
Research & Publications (20)
Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148.
PMID 18591547·J Clin Oncol·2008
3-trial
Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
PMID 16398726·Transfusion·2006
4-observational
Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116).
PMID 12694666·Gynecol Oncol·2003
3-trial
Detection of heat-stable antigens of Campylobacter jejuni and C. coli by direct agglutination and passive hemagglutination.
PMID 11880429·J Clin Microbiol·2002
8-other
Clinical development of P glycoprotein modulators in oncology.
PMID 11990771·Novartis Found Symp·2002
6-review
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors.
PMID 19383817·Clin Cancer Res·2009
3-trial
Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study.
PMID 19029964·Bone Marrow Transplant·2009
3-trial
Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II study.
PMID 19476988·Gynecol Oncol·2009
3-trial
Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.
PMID 19135709·Gynecol Oncol·2009
3-trial
Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: a phase II study.
PMID 19520420·Gynecol Oncol·2009
3-trial
Safety and efficacy of patupilone in patients with advanced ovarian, primary fallopian, or primary peritoneal cancer: a phase I, open-label, dose-escalation study.
PMID 19451434·J Clin Oncol·2009
3-trial
Performance of dedicated versus integrated bipolar defibrillator leads with CRT-defibrillators: results from a Prospective Multicenter Study.
PMID 19170903·Pacing Clin Electrophysiol·2009
4-observational
A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies.
PMID 18519776·Clin Cancer Res·2008
3-trial
Molecular targeted agents combined with chemo-radiation in the treatment of locally advanced cervix cancer.
PMID 18474021·Rev Recent Clin Trials·2008
6-review
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
PMID 18423560·Gynecol Oncol·2008
3-trial
A rare case of ectopic adrenocorticotropic hormone syndrome in small cell carcinoma of the vagina: a case report.
PMID 18369310·J Low Genit Tract Dis·2008
5-case
Laboratory diagnosis of Clostridium difficile-associated disease in the Republic of Ireland: a survey of Irish microbiology laboratories.
PMID 18353502·J Hosp Infect·2008
8-other
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab.
PMID 19010874·Clin Cancer Res·2008
3-trial
Polaron hopping in some biomolecular solids and their charge transfer complexes.
PMID 19239130·Indian J Biochem Biophys·2008
8-other
Hospital infection society prevalence survey of Healthcare Associated Infection 2006: comparison of results between Northern Ireland and the Republic of Ireland.
PMID 18547678·J Hosp Infect·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2349 N CALIFORNIA ST
STOCKTON, CA 95204 - Phone
- (209) 469-2229
Quick Facts
- NPI
- 1356736508
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile